Lisa A. Hayes
Keine laufenden Positionen mehr
Karriereverlauf von Lisa A. Hayes
Ehemalige bekannte Positionen von Lisa A. Hayes
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CYTEIR THERAPEUTICS, INC. | Investor Relations Kontakt | 01.02.2021 | 01.02.2023 |
Public Communications Contact | 01.02.2021 | 01.02.2023 | |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Investor Relations Kontakt | - | - |
Public Communications Contact | - | - | |
PROQR THERAPEUTICS N.V. | Investor Relations Kontakt | 13.12.2018 | - |
Public Communications Contact | 13.12.2018 | - | |
CELGENE | Public Communications Contact | - | - |
Ausbildung von Lisa A. Hayes
St. Joseph's University | Masters Business Admin |
New York University | Graduate Degree |
Seton Hall University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Niederlande | 2 |
Operativ
Public Communications Contact | 4 |
Investor Relations Contact | 3 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 4 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PROQR THERAPEUTICS N.V. | Health Technology |
Private Unternehmen | 3 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Cyteir Therapeutics, Inc.
Cyteir Therapeutics, Inc. BiotechnologyHealth Technology Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company was founded by Kevin Mills and Timothy Romberger in June 2012 and is headquartered in Lexington, MA. | Health Technology |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Commercial Services |
- Börse
- Insiders
- Lisa A. Hayes
- Erfahrung